Actively Recruiting
A Clinical Study Evaluating the Preliminary Anti-tumor Efficacy and Safety of Hemay181
Led by Ganzhou Hemay Pharmaceutical Co., Ltd · Updated on 2026-03-03
24
Participants Needed
1
Research Sites
86 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
An open-label phase I clinical study,which enrolled subjects with advanced solid tumors who have failed to respond to adequate standard therapies or have no available effective standard therapy.
CONDITIONS
Official Title
A Clinical Study Evaluating the Preliminary Anti-tumor Efficacy and Safety of Hemay181
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects who voluntarily signed a written informed consent form before the start of the study
- Subjects with pathologically confirmed advanced solid tumors who have failed standard therapies or have no effective standard therapy
- Subjects with at least one measurable lesion evaluable by CT/MRI according to RECIST V1.1
- At least 4 weeks or 5 half-lives since last treatment with recovery to Grade 1 or less adverse reactions (except alopecia any grade, hyperpigmentation any grade, or peripheral sensory neuropathy Grade 2 or less)
- ECOG performance status of 0-1
- Expected survival longer than 3 months
- Women of childbearing potential and their partners not planning pregnancy and using effective contraception from consent until 6 months after last dose
You will not qualify if you...
- Women who are pregnant or breastfeeding
- Positive tests for HIV, syphilis, hepatitis B with high HBV-DNA, or hepatitis C with high HCV-RNA
- Received drug treatment from another clinical trial within 4 weeks before enrollment
- Allergy to Hemay181 or its ingredients
- History of alcohol or drug abuse, dependence, or severe mental illness
- Any clinical or laboratory abnormalities making participation unsuitable as judged by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xinxiang Medical University First Affiliated Hospital
Xinxiang, Henan, China, 45310
Actively Recruiting
Research Team
X
Xu, Doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here